Shuguang Zhang | |
---|---|
Born | |
Known for | self-assembling peptides |
Academic background | |
Education | University of California, Santa Barbara (Ph.D.), Sichuan University (B.S.) |
Doctoral advisor | Eduardo Orias |
Academic work | |
Discipline | Biochemistry |
Sub-discipline | Molecular Architecture |
Institutions | Massachusetts Institute of Technology |
Website | https://www.media.mit.edu/people/shuguang/overview/ |
Shuguang Zhang is an American biochemist. He is at the MIT Media Lab's Laboratory for Molecular Architecture. [1] Shuguang Zhang's research focuses on designs of biological molecules,particularly proteins and peptides. He has published over 210 scientific papers,which have cumulatively been cited over 41,400 times with an h-index of 97. [2] [3] On the “Updated science-wide author databases of standardizes citation indicators”, [4] he is ranked 18th worldwide in the field of Biomedical Engineering. Zhang is also a co-founder and board member of Molecular Frontiers Foundation, [5] which organizes annual Molecular Frontiers Symposia in Sweden and around the world. [6] The selected winners are awarded Molecular Frontiers Inquiry Prize. [7]
Shuguang Zhang received his B.S. in biochemistry from Sichuan University in 1980 and Ph.D. in Biochemistry &Molecular Biology from University of California at Santa Barbara in 1988 (under mentorship of Eduardo Orias). The same year,he joined MIT to work with Alexander Rich.
In 1990,Shuguang Zhang made a serendipitous discovery of a self-assembling peptide in yeast protein Zuotin. [8] [9] This discovery led to the development of a new field of peptide nanobiotechnology and to designs of a variety of self-assembling peptides for widespread uses,including peptide hydrogels in materials science,3D tissue cell culture and tissue engineering,nanomedicine,sustained molecular releases,clinical and surgical applications. [10] [11] [12] [13] He co-founded a startup company 3DMatrix that brings the self-assembling peptide materials to human clinical for treatment of diabetic ulcers,bedsores (pressure ulcers) and for accelerated wound healings as well as surgical uses. [14] Many self-assembling peptide scaffold hydrogel products have received approvals from the US FDA,European Medicine Agency (EMA),Japan Medical Agency and medical approval agency in Chengdu,China. [15]
Less widely-known,Zhang invented the QTY Code as a systematic method of rendering insoluble peptide sequences water-soluble,to facilitate biochemical research,while retaining the native conformation and functionality. [16] [17] [18] [19] In 2011,Shuguang Zhang started to design membrane proteins,because there are ~26% of genes that code for membrane proteins in genomes which are crucial for both internal and external cellular communications. [20] [21] He conceived a simple molecular QTY Code,namely Glutamine (Q),Threonine (T) and Tyrosine (Y) to systematically replace the hydrophobic amino acids Leucine (L),Valine (V),Isoleucine (I),and Phenylalanine (F) in the 7 transmembrane alpha-helices of G protein-coupled receptors (GPCRs). [16] [18] Thus,it changes the water-insoluble form of membrane proteins,including GPCRs,into a water-soluble form. The QTY code results suggest that despite 46%-56% transmembrane alpha-helices changes,water-soluble QTY variants still maintain stable structures and biological function,namely,ligand-binding activities. This simple QTY code is a likely useful tool and has big impact for designs of water-soluble variants of previously water-insoluble and perhaps aggregated proteins,including amyloids. [16]